DiePharmazie 6/2010



Bodor N, Buchwald P: Recent advances in retrometabolic drug design (RMDD) and development
doi : 10.1691/ph.2010.0523R

Loftsson T: Aqueous solubility and true solutions
doi: 10.1691/ph.2010.0034R


Original articles

Hidvégi E, Somogyi GP: Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption
doi: 10.1691/ph.2010.0035R

Wu WM, Tang Y, Buchwald P, Bodor N: Pharmacokinetics and cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats
doi: 10.1691/ph.2010.0524R

Wu B, Derendorf H: Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure
doi: 10.1691/ph.2010.0032R

Buchwald P, Bocca N, Marzorati S, Hochhaus G, Bodor N, Stabler C, Kenyon NS, Inverardi L, Molano RD, Ricordi C, Pileggi A: Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation
doi: 10.1691/ph.2010.0525R

Pinto E, Zhang B, Song S, Bodor N, Buchwald P, Hochhaus G: Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant
doi: 10.1691/ph.2010.0033R

Berta E, Samson L, Lenkey A. Erdei A, Cseke B, Jenei K, Major T, Jakab A, Jenei Z, Paragh G, Nagy EV, Bodor M: Evaluation of the thyroid function of healthy pregnant women by five different hormone assays
doi: 10.1691/ph.2010.0030R

Murakami T, Yokooji T, Mori N: Study on absorption sites of quinidine and methotrexate in rat intestine
doi: 10.1691/ph.2010.0031R

All research papers in thes issue were presented during the 7th Conference on Retrometabolism Based Drug Design and Targeting, May 10-13, 2010, Orlando, Florida, U. S. A.